Skip to content
Pharmaceutical Newswire
  • Pharmaceutical News
  • Pharmaceutical Media Releases
  • About
  • Contact

West Pharmaceutical Services, Inc.: Life Science Toolmakers Help Ideas Become Drugs While Reinforcing Their Moats

June 2, 2023

Find the latest West Pharmaceutical Services, I (WST) stock forecast based on top analyst’s estimates, plus more investing and trading data from Yahoo Finance

UK-based pharmaceutical company with Portland presence goes private in $5.6B deal

June 2, 2023

A Swedish company is making a $5.6 billion (£4.5 billion) deal to buy a Northwich, England-based veterinary pharmaceuticals company with a Portland office. The Dechra Veterinary Products deal could be one of the biggest private equity transactions of 2023 in the United Kingdom.

Taro Pharmaceutical: Potential Value In Sun Pharma Offer

June 2, 2023

Taro Pharmaceutical received a $38/share offer from Sun Pharma last month. Read why the deal represent a decent premium to TARO stock’s market value at the time.

Man gets 6 years for Lake Worth’s ‘largest illicit pharmaceutical seizure’

June 2, 2023

The man behind the largest pharmaceutical seizure in the Lake Worth Police Department’s history was sentenced to just under six years in federal prison.

Are pharmaceutical shortages part of the new health care norm?

June 2, 2023

Doctors and pharmacists in Florida aren’t strangers to diminished inventories. Here’s a closer look at the current shortage and how the state is managing.

Ohio among states agreeing to $102.5M antitrust settlement with pharmaceutical company

June 2, 2023

A pharmaceutical company being sued for state and federal antitrust law violations has agreed on a settlement with 41 states and the District of Columbia, according to an Ohio Attorney General’s Office release.

UK-based pharmaceutical company with Kansas City presence goes private in $5.6B deal

June 2, 2023

A manufacturer, distributor and marketer of veterinary pharmaceuticals with its North American headquarters in the Kansas City area has agreed to a multi-billion-dollar buyout.

Rohto Pharmaceutical (TYO:4527) Price Target Increased by 8.11% to 3,109.54

June 2, 2023

The average one-year price target for Rohto Pharmaceutical (TYO:4527) has been revised to 3,109.54 / share. This is an increase of 8.11% from the prior estimate of 2,876.40 dated May 10, 2023. The price target is an average of many targets provided by analysts.

Advanced manufacturing center forms partnership to research pharmaceutical ingredients

June 1, 2023

Leaders of the initiative to build an advanced manufacturing center in north St. Louis announced a partnership Thursday with a nonprofit group to lead research and development of pharmaceutical ingredients. The Active Pharmaceutical Ingredient (API …

Pharmaceutical Industry Ought To Justify Drug Prices On Value, Not R&D Costs

June 1, 2023

Sometimes a lot of R&D goes into only marginally effective drugs. Other times, drugs with relatively minimal amounts of R&D turn out to have a lot of value.

Older posts
Page1 Page2 … Page5 Next →
© 2003 - 2023 Copyright Pharmaceutical Newswire
Terms of Use
Privacy Notice